5 New Diabetes Technologies and Treatments

Publication
Slideshow
Drug Topics JournalDrug Topics October 2019
Volume 163
Issue 10

Noteworthy diabetes management products and updates making waves this year.

Like other areas of healthcare, diabetes management in 2019 has been experiencing a combination of new device developments and improvements, technological advancements, new drug approvals, and new partnerships offering a glimpse of distant future possibilities. Here are five noteworthy products and updates that are making waves in the diabetes management space this year:

Download Issue PDF
Articles in this issue
statins heart rate
The Truth About Statins
color splash
Opinion: Color Coded Inhalers
tooth made out of pills
Pharmacist Collaborations Must Extend to Dentists
money in pill vial
Contemplating the Future of List Prices
New Drug Review: Tafamidis Meglumine for Cardiomyopathy
New Drug Review: Tafamidis Meglumine for Cardiomyopathy
genetics
Life-Altering Gene Therapy Pipeline Poses Challenges
empty pill bottles
Solving the Drug Shortage Burden
transgender hand with flag paint
Providing Healthcare to Transgender Patients
neon prep sign
State Laws May Determine Access to Pharmacy-based PrEP Clinics
Merger arrow
Official CVS/Aetna Merger: Greater Convenience, Less Cost Reform
Alternative Approaches to Opioids
Alternative Approaches to Opioids
diabetes
5 Types of Diabetes Patients Who Need More Management
5 New Diabetes Technologies and Treatments
5 New Diabetes Technologies and Treatments
woman holding stomach in pain
Lupus and Celiac Disease: What Pharmacists Need to Know
lefamulin product image
Lefamulin Could Be Vital in the Pneumonia Fight
Recent Videos
Related Content
Q&A: The Importance of ASHP’s 2025 Pharmacy Forecast

Q&A: The Importance of ASHP’s 2025 Pharmacy Forecast

Brian Nowosielski;Joseph T. DiPiro, PharmD, FCCP, FAAAS
January 17th 2025
Article

Joseph DiPiro, PharmD, FCCP, FAAAS, editor of the American Society of Health-System Pharmacists 2025 Pharmacy Forecast, discussed key themes in the forecast that will impact health-system pharmacy in 2025.

Looking to the Future of Independent Pharmacy

Looking to the Future of Independent Pharmacy

Miranda Hester
July 13th 2022
Podcast

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

Q&A: How Specific GLP-1s Impact Different Patient Populations | ASHP Midyear

Q&A: How Specific GLP-1s Impact Different Patient Populations | ASHP Midyear

Brian Nowosielski;Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP;Ashley Gallagher
January 13th 2025
Article

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.

Easing The Burden of Burnout With Technology

Easing The Burden of Burnout With Technology

January 31st 2022
Podcast

Lani Bertrand, RPh, joins the latest episode of Over The Counter to discuss the role of technology in easing burnout during the COVID-19 pandemic.

Q&A: Factors Showing Tirzepatide is More Beneficial Than Semaglutide | ASHP Midyear

Q&A: Factors Showing Tirzepatide is More Beneficial Than Semaglutide | ASHP Midyear

Brian Nowosielski;Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP;Ashley Gallagher
January 7th 2025
Article

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed the benefits of tirzepatide compared with semaglutide.

Quality Improvement Initiatives Could Help Increase Glucagon Prescribing

Quality Improvement Initiatives Could Help Increase Glucagon Prescribing

Killian Meara
January 3rd 2025
Article

A study found that sending a letter to providers about standards of care and glucagon preparations could increase glucagon prescription rates.

© 2025 MJH Life Sciences

All rights reserved.